Application of mesenchymal stem cells derived from the umbilical cord or Wharton’s jelly and their extracellular vesicles in the treatment of various diseases
Tissue and Cell,
Год журнала:
2024,
Номер
89, С. 102415 - 102415
Опубликована: Май 27, 2024
Язык: Английский
Autophagy activation within inflammatory microenvironment improved the therapeutic effect of MSC-Derived extracellular Vesicle in SLE
Shuzhen Liao,
Fengbiao Guo,
Zengzhi Xiao
и другие.
Journal of Advanced Research,
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 1, 2025
Язык: Английский
Cell Therapies for Acute Radiation Syndrome
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(13), С. 6973 - 6973
Опубликована: Июнь 26, 2024
The
risks
of
severe
ionizing
radiation
exposure
are
increasing
due
to
the
involvement
nuclear
powers
in
combat
operations,
use
power,
and
existence
terrorist
threats.
Exposure
a
whole-body
dose
above
about
0.7
Gy
results
H-ARS
(hematopoietic
acute
syndrome),
which
is
characterized
by
damage
hematopoietic
system;
higher
doses
result
further
gastrointestinal
nervous
systems.
Only
few
medical
countermeasures
for
ARS
currently
available
approved
use,
although
others
development.
Cell
therapies
(cells
or
products
produced
cells)
complex
therapeutics
that
show
promise
treatment
injury
have
been
shown
reduce
mortality
morbidity
animal
models.
Since
clinical
trials
cannot
be
ethically
conducted,
testing
extremely
important.
Here,
we
describe
cell
tested
Both
cells
appear
promote
survival
lessen
tissue
after
irradiation,
mechanisms
not
clear.
Because
often
occurs
conjunction
with
other
traumatic
injuries,
models
combined
involving
future
countermeasure
these
problems
also
discussed.
Язык: Английский
Revisiting the role of mesenchymal stromal cells in cancer initiation, metastasis and immunosuppression
Experimental Hematology and Oncology,
Год журнала:
2024,
Номер
13(1)
Опубликована: Июль 1, 2024
Abstract
Immune
checkpoint
blockade
(ICB)
necessitates
a
thorough
understanding
of
intricate
cellular
interactions
within
the
tumor
microenvironment
(TME).
Mesenchymal
stromal
cells
(MSCs)
play
pivotal
role
in
cancer
generation,
progression,
and
immunosuppressive
microenvironment.
Within
TME,
MSCs
encompass
both
resident
circulating
counterparts
that
dynamically
communicate
actively
participate
TME
immunosurveillance
response
to
ICB.
This
review
aims
reevaluate
various
facets
MSCs,
including
their
potential
self-transformation
function
as
cancer-initiating
contributions
creation
conducive
environment
for
proliferation
metastasis.
Additionally,
we
explore
immune
regulatory
functions
tumor-associated
(TA-MSCs)
MSC-derived
extracellular
vesicles
(MSC-EVs)
with
analysis
connections
between
tissue-resident
MSCs.
A
comprehensive
dynamics
MSC-immune
cell
communication
heterogeneous
cargo
tumor-educated
versus
naïve
may
unveil
new
MSC-mediated
pathway
can
be
targeted
enhance
control
by
Язык: Английский
Optimizing Mesenchymal Stem Cells for Regenerative Medicine: Influence of Diabetes, Obesity, Autoimmune, and Inflammatory Conditions on Therapeutic Efficacy: A Review
Medical Science Monitor,
Год журнала:
2024,
Номер
30
Опубликована: Июль 23, 2024
Mesenchymal
stem
cells
(MSCs)
are
a
promising
tool
that
may
be
used
in
regenerative
medicine.
Thanks
to
their
ability
differentiate
and
paracrine
signaling,
they
can
the
treatment
of
many
diseases.
Undifferentiated
MSCs
support
regeneration
surrounding
tissues
through
secreted
substances
exosomes.
This
is
possible
thanks
production
growth
factors.
These
factors
stimulate
neighboring
cells,
have
an
anti-apoptotic
effect,
angiogenesis,
also
immunomodulatory
effect.
The
level
vary
depending
on
Apart
from
donor's
health
condition,
it
influenced
by
source
MSCs,
methods
harvesting,
even
banking
cells.
work
review
research
how
patient's
condition
affects
properties
obtained
MSCs.
discusses
impact
diabetes,
obesity,
autoimmune
diseases,
inflammation,
as
well
harvesting
phenotype,
differentiation
capacity,
anti-inflammatory,
angiogenic
effects,
proliferation
potential
Knowledge
about
specific
clinical
allows
for
better
use
more
appropriate
targeting
procedures
collecting,
multiplying,
these
subsequent
use.
article
aims
characteristics,
banking,
signaling
role
inflammatory
Язык: Английский
Tailoring cell therapies for diabetic metabolic phenotypes: a comparative study on the efficacy of various umbilical cord-derived cell regimens
Stem Cells Translational Medicine,
Год журнала:
2024,
Номер
unknown
Опубликована: Ноя. 19, 2024
Abstract
Given
the
high
heterogeneity
of
type
2
diabetes
mellitus
(T2DM),
it
is
imperative
to
develop
personalized
stem
cell
infusion
regimen
for
targeted
metabolic
phenotype
in
order
ensure
optimal
therapeutic
efficacy.
In
this
study,
we
conducted
a
comparative
analysis
4
regimens
involving
single
and
repeated
infusions
human
umbilical
cord
Wharton’s
jelly-derived
MSCs
(hucMSCs),
blood
mononuclear
cells
(UCB),
sequential
hucMSCs
UCB
T2DM
rats.
Results
showed
all
exhibited
comparable
efficacy
lowering
fasting
glucose
levels
suppressing
glucagon
secretion.
Single
double
tendency
migrate
liver,
thereby
better
at
ameliorating
hepatic
metabolism
by
enhancing
glycogen
synthesis
storage,
promoting
glycolysis,
inhibiting
gluconeogenesis,
improving
insulin
signal
transduction.
The
demonstrated
specific
tropism
toward
pancreas,
leading
prolonged
glucose-lowering
effects
following
tolerance
test,
restoration
early-phase
secretion,
stimulation
islet
beta
proliferation
improvement
beta/alpha
ratio.
Multiple
injections,
regardless
type,
reduced
expression
systemic
chronic
inflammatory
markers
such
as
IL-1β,
IL-6,
IL-17,
IL-22,
IFN-γ.
Finally,
dose
greater
target
visceral
fat
enhanced
effectiveness
regulating
total
cholesterol
triglycerides.
conclusion,
our
study
provided
diverse
phenotypes,
offering
improved
treatment
alternatives
future
clinical
trials
applications.
Язык: Английский
Ingenol-3-Angelate Enhances the B Cell Inhibitory Potential of Mesenchymal Stem Cells, Leading to Marked Alleviation of Lupus Symptoms in MRL.faslpr Mice
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(23), С. 12625 - 12625
Опубликована: Ноя. 25, 2024
Systemic
lupus
erythematosus
(SLE)
is
a
chronic
autoimmune
disease
characterized
by
autoantibody
production
hyper-activated
B
cells.
Although
mesenchymal
stem
cells
(MSCs)
relieve
symptoms
inhibiting
mainly
T
cells,
whether
MSCs
also
inhibit
has
been
controversial.
Here,
we
found
that
naïve
inhibited
IFN-γ
but
not
IgM
We
used
chemical
approach
to
prime
ingenol-3-angelate
(I3A),
non-tumor-promoting
phorbol
ester,
activated
in
TGF-β1-dependent
manner.
showed
IL-1β
induced
continuously
secrete
TGF-β1,
which
directly
whereas
did
not.
I3A-treated
were
better
than
at
ameliorating
SLE
MRL.
Язык: Английский
Mesenchymal stem cell-derived extracellular vesicles alleviate imiquimod-induced psoriasis symptoms in a mouse disease model
bioRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2024,
Номер
unknown
Опубликована: Сен. 16, 2024
Abstract
Psoriasis
is
an
immune
mediated,
chronic
inflammatory
skin
disease.
Mesenchymal
stem
cell-derived
extracellular
vesicles
(MSC-EVs)
have
inherent
immunomodulatory
potency
from
their
parental
cells,
the
mesenchymal
cells
(MSCs).
In
this
study,
we
revealed
application
potential
of
MSC-EVs
to
alleviate
psoriatic
symptoms
in
imiquimod-induced
psoriasis
mouse
model.
Язык: Английский